Nothing Special   »   [go: up one dir, main page]

EP1955687B1 - Packaged product mix - Google Patents

Packaged product mix Download PDF

Info

Publication number
EP1955687B1
EP1955687B1 EP07101975A EP07101975A EP1955687B1 EP 1955687 B1 EP1955687 B1 EP 1955687B1 EP 07101975 A EP07101975 A EP 07101975A EP 07101975 A EP07101975 A EP 07101975A EP 1955687 B1 EP1955687 B1 EP 1955687B1
Authority
EP
European Patent Office
Prior art keywords
medicaments
product combination
blister pack
packaged product
receiving compartments
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Not-in-force
Application number
EP07101975A
Other languages
German (de)
French (fr)
Other versions
EP1955687A1 (en
Inventor
Edwin Kohl
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to ES07101975T priority Critical patent/ES2338474T3/en
Application filed by Individual filed Critical Individual
Priority to PL07101975T priority patent/PL1955687T3/en
Priority to DK07101975.6T priority patent/DK1955687T3/en
Priority to AT07101975T priority patent/ATE456356T1/en
Priority to DE502007002736T priority patent/DE502007002736D1/en
Priority to EP07101975A priority patent/EP1955687B1/en
Priority to AU2008213050A priority patent/AU2008213050A1/en
Priority to CA002677292A priority patent/CA2677292A1/en
Priority to JP2009548650A priority patent/JP2010517651A/en
Priority to US12/524,627 priority patent/US20100108559A1/en
Priority to PCT/EP2008/050953 priority patent/WO2008095810A1/en
Publication of EP1955687A1 publication Critical patent/EP1955687A1/en
Application granted granted Critical
Publication of EP1955687B1 publication Critical patent/EP1955687B1/en
Not-in-force legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/03—Containers specially adapted for medical or pharmaceutical purposes for pills or tablets
    • A61J1/035—Blister-type containers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J7/00—Devices for administering medicines orally, e.g. spoons; Pill counting devices; Arrangements for time indication or reminder for taking medicine
    • A61J7/04—Arrangements for time indication or reminder for taking medicine, e.g. programmed dispensers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J2205/00—General identification or selection means
    • A61J2205/20—Colour codes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J2205/00—General identification or selection means
    • A61J2205/40—General identification or selection means by shape or form, e.g. by using shape recognition
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/007—Marking tablets or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/06—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of pills, lozenges or dragees

Definitions

  • the invention relates to a packaged product combination comprising a plurality of different medicaments or the like, as well as an associated method for packaging and packaging such a product combination.
  • WO 2005/102862 A1 is a blister pack for the weekly drug needs of a patient known to take the medication in a order by date, day of the week and time of day (morning, noon, evening and possibly night) order.
  • the receiving compartments of the blister pack for receiving the respective medicaments are arranged in matrix form and have seven daily lines, each with at least three time-of-day compartments, which are closed overall by a continuous blister foil.
  • Affixed to the blister pack is a carton-shaped lid, on which the patient-individual the composition of the individual time of day compartments and prescribing information regarding the respective medicaments are contained.
  • Such packaging units are for patients who need to take several different medications regularly, a help not only to remember the intake of important drugs and on the other hand to keep a reliable overview of which medications have already been taken to a possibly harmful over-medication avoid.
  • the Indian WO 2005/102862 A1 described weekly blister so reliably supports needs-based medication of patients and is at the same time inexpensively manufactured and individually equipped by means of a pick and place machine for a large number of patients.
  • the EP 0210820 A2 describes a tablet package for oral contraceptives in which tablets with different hormone compositions are arranged in different rows and have different colors.
  • the DE 2834226 describes pressed bodies, in particular medicaments, which consist of juxtaposed areas of different composition, the individual areas being clearly separable from one another without mixing their constituents.
  • a packaged product combination according to claim 1 comprising a plurality of different drugs or the like.
  • the form and / or color of the medication itself indicates an application information to the drug, namely a recommended intake time in relation to a meal.
  • a recommended intake time for example, preparations to be taken before a meal may be oblong, triangular shaped, taken during the meal and taken post-meal be. If the application time with respect to a meal does not matter, for example, a spherical shape may be provided.
  • the time of ingestion with respect to a meal can also be coded by a color, e.g. yellow before the meal, green in the meantime, blue after and red if the time of taking it does not matter.
  • shape-coding is more suitable for visually impaired patients.
  • the blister pack is provided with a plurality of storage compartments, each closed by a film, for receiving a number of medicaments, which storage compartments are each assigned to a specific application time (morning, noon, evening and possibly night) within the specified period of application.
  • the receiving compartments of the blister pack are arranged in a matrix form with a number of lines for application days and columns for application times during the day (morning, noon, evening and optionally at night).
  • the blister pack may preferably be designed as a weekly blister for the needs of a week.
  • the blister pack can have perforation sections which allow the separation of individual (daily) lines of the matrix-shaped blister pack.
  • the product compilation can be designed as a personalized product compilation comprising an individually defined drug compilation for a specific person for a defined period of time.
  • the products may be medications, vitamin supplements, dietary supplements, etc.
  • the invention also proposes a method for packaging and packaging a product combination comprising a plurality of different medicaments or the like according to claim 7.
  • FIG. 1 shows an embodiment of a personalized blister pack according to the invention 20.
  • This is designed as a so-called weekly blister for supplying a person or a patient with medicines and similar products such as vitamin supplements, dietary supplements, etc. for a period of one week.
  • the invention is not limited to a specific period of time.
  • For each day of the week is provided in the total matrix-shaped blister pack 20 a detachable by a perforation line of four in the example shown four storage compartments 22, each of the applied products for "early"("morning"),”noon”,”evening or "at night” or "for breakfast", “for lunch”, “for dinner” and “before bedtime".
  • a different number of receiving compartments 22 may be provided.
  • the - in the in FIG. 1 shown embodiment - a total of 28 receiving compartments 22 are made of a preferably transparent thermoplastic material inexpensively mass-produced by deep drawing and have enough space for a plurality of tablets, capsules, dragees, etc. All receiving compartments 22 can by a common film 30, for example.
  • a thin Aluminum foil to be closed and provided with symbols for the intake time (morning, noon, evening, night).
  • a preferably hinged to the blister pack 20 molded lid may be provided to cover the film 30 with labeling surfaces for printing detailed application information.
  • the patient By tearing the thin foil, the patient can comfortably remove the products to be taken at the time of day.
  • the perforation 24 of both the receiving compartments 22 forming plastic board and the film 30 can be separated from the blister pack 20 day strips for convenient driving.
  • FIG. 2 shows the in FIG. 1 pictured weekly blister 20 in cross-sectional view.
  • the four storage compartments 22 for morning, noon, evening and night are easy to recognize; as well as the products 10 therein. These have different shapes (oblong, spherical or cylindrical or triangular), each giving an application condition, for example, the time of ingestion with respect to a meal.
  • FIG. 3 shows by way of example four different product forms, in the upper row in side or partial perspective view, in the lower row in supervision.
  • FIG. 3a shows a spherical
  • FIG. 3b a circular or cylindrical
  • Figure 3c an oblong (cigar-shaped) and 3d figure a triangular preparation.
  • the cylindrical shape may indicate a pre-meal intake, the oblong shape during the meal, and the triangular shape after the meal. If the intake time with respect to a meal does not matter, for example, the Be used spherical shape. This allows the patient to easily find out which preparations to take before, during and after meals.
  • a color coding (not shown in the figures) of the intake times may be provided, for example, yellow tablets before the meal, green during, blue after and red, if the time of administration is no matter.
  • product information may also be coded by shape and / or color within the scope of the invention.
  • time of administration with respect to one meal may be indicated by the form and another preparation-specific information by the color.
  • the packaged product combination according to the invention and the method according to the invention support a need-based medication of the patient, so that he is able to care for himself longer and is not dependent on in-patient care.

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medical Informatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Packages (AREA)
  • Bakery Products And Manufacturing Methods Therefor (AREA)
  • Devices For Executing Special Programs (AREA)
  • Footwear And Its Accessory, Manufacturing Method And Apparatuses (AREA)
  • Confectionery (AREA)
  • Basic Packing Technique (AREA)

Abstract

The packaged product combination comprises a number of different medicaments of different shape or color. The form or color of the medicaments provides application information to the respective medicaments. The application information is a recommended dosage time in relation to meal times. A blister pack (20) is provided with multiplicity, by a foil (30) locked in each case compartment (22) for the absorption of a number of medicaments, which compartment is assigned to a certain application time of the medicaments. An independent claim is also included for a method for manufacturing and packing of a product combination, which involves utilizing a number of different medicaments of different shape or color.

Description

Gebiet der ErfindungField of the invention

Die Erfindung betrifft eine abgepackte Produktzusammenstellung umfassend mehrere unterschiedliche Medikamente oder dgl. sowie ein zugehöriges Verfahren zur Konfektionierung und Verpackung einer derartigen Produktzusammenstellung.The invention relates to a packaged product combination comprising a plurality of different medicaments or the like, as well as an associated method for packaging and packaging such a product combination.

Verwandter Stand der TechnikRelated prior art

Aus der WO 2005/102862 A1 ist eine Blisterpackung für den wöchentlichen Medikamentenbedarf eines Patienten bekannt, der die Medikamente in einer nach Datum, Wochentag und Tageszeit (Morgen, Mittag, Abend und ggf. Nacht) geordneten Folge einnehmen soll. Die Aufnahmefächer der Blisterpackung zur Aufnahme der jeweiligen Medikamente sind in Matrixform angeordnet und haben sieben Tageszeilen mit jeweils mindestens drei Tageszeit-Fächern, die insgesamt durch eine zusammenhängende Blisterfolie verschlossen sind. An der Blisterpackung angebracht ist ein kartonförmiger Deckel, auf dem patientenindividuell die Zusammensetzung der einzelnen Tageszeit-Fächer sowie Verschreibungsinformationen betreffend die jeweiligen Medikamente enthalten sind.From the WO 2005/102862 A1 is a blister pack for the weekly drug needs of a patient known to take the medication in a order by date, day of the week and time of day (morning, noon, evening and possibly night) order. The receiving compartments of the blister pack for receiving the respective medicaments are arranged in matrix form and have seven daily lines, each with at least three time-of-day compartments, which are closed overall by a continuous blister foil. Affixed to the blister pack is a carton-shaped lid, on which the patient-individual the composition of the individual time of day compartments and prescribing information regarding the respective medicaments are contained.

Derartige Verpackungseinheiten sind für Patienten, die regelmäßig mehrere verschiedene Medikamente einnehmen müssen, eine Hilfe dafür, einerseits das Einnehmen wichtiger Medikamente nicht zu vergessen und andererseits auch einen zuverlässigen Überblick darüber zu behalten, welche Medikamente schon eingenommen worden sind, um eine unter Umständen schädliche Übermedikation zu vermeiden. Der in der WO 2005/102862 A1 beschriebene Wochenblister unterstützt so zuverlässig eine bedarfsgerechte Medikation der Patienten und ist gleichzeitig preisgünstig herstellbar und mittels einer Bestückungsmaschine für eine große Zahl von Patienten individuell bestückbar.Such packaging units are for patients who need to take several different medications regularly, a help not only to remember the intake of important drugs and on the other hand to keep a reliable overview of which medications have already been taken to a possibly harmful over-medication avoid. The Indian WO 2005/102862 A1 described weekly blister so reliably supports needs-based medication of patients and is at the same time inexpensively manufactured and individually equipped by means of a pick and place machine for a large number of patients.

Die Tageszeit-Fächer des in der WO 2005/102862 A1 beschriebenen Wochenblisters geben dem Patienten auf einfache und eindeutige Weise an, zu welcher Tageszeit ein Medikament einzunehmen ist. Für die Wirksamkeit vieler Medikamente ist es jedoch bedeutsam, ob das Präparat vor, während oder nach einer Mahlzeit eingenommen wird. Diese zusätzliche Anwendungsinformation wird dem Patienten bei dem aus der WO 2005/102862 A1 bekannten Wochenblister durch aufgedruckte Anwendungshinweise auf einem Deckelabschnitt des Wochenblisters mitgeteilt. Diese schriftlichen Anwendungshinweise .sind jedoch aufgrund der Vielzahl der notwendigen Angaben insbesondere für ältere und insbesondere sehbehinderte Patienten aufgrund der aus Platzgründen limitierten Schriftgröße ggf. schwierig zu lesen.The daytime fan of the in the WO 2005/102862 A1 described Wochenblisters give the patient in a simple and clear way, at what time of day to take a drug. However, it is important for the effectiveness of many medications whether the preparation is taken before, during or after a meal. This additional application information is provided to the patient at the time of WO 2005/102862 A1 known Wochenblister notified by printed instructions on a cover section of the weekly. However, these written Anwendungshinweise.sind are due to the large number of necessary information, especially for older and especially visually impaired patients due to the limited space reasons font size difficult to read.

Die EP 0210820 A2 beschreibt eine Tablettenpackung für orale Kontrazeptiva, bei der Tabletten mit unterschiedlichen Hormonzusammensetzungen in unterschiedlichen Reihen angeordnet sind und unterschiedliche Farben aufweisen.The EP 0210820 A2 describes a tablet package for oral contraceptives in which tablets with different hormone compositions are arranged in different rows and have different colors.

Die DE 2834226 beschreibt Preßkörper, insbesondere Medikamente, die aus nebeneinander angeordneten Bereichen unterschiedlicher Zusammensetzung bestehen, wobei die einzelnen Bereiche ohne Vermischung ihrer Bestandteile klar voneinander trennbar sind.The DE 2834226 describes pressed bodies, in particular medicaments, which consist of juxtaposed areas of different composition, the individual areas being clearly separable from one another without mixing their constituents.

Zusammenfassung der EreindungSummary of the erection

Es ist daher eine Aufgabe der Erfindung, eine abgepackte Produktzusammenstellung umfassend mehrere unterschiedliche Medikamente oder dgl. sowie ein zugehöriges Verfahren zur Konfektionierung und Verpackung einer derartigen Produktzusammenstellung vorzuschlagen, welche dem Patienten zusätzliche Anwendungsinformation zu dem jeweiligen Medikament liefert, ohne dass dieser schriftliche Hinweise lesen muß.It is therefore an object of the invention to propose a packaged product combination comprising a plurality of different medicaments or the like as well as an associated method for packaging and packaging such a product combination, which provides the patient with additional application information about the respective medicament, without this having to read written instructions.

Gelöst wird die Aufgabe durch eine abgepackte Produktzusammenstellung gemäß Anspruch 1 umfassend mehrere unterschiedliche Medikamente oder dgl., wobei die Form und/oder Farbe der Medikamente selbst eine Anwendungsinformation zu dem Medikament, nämlich einen empfohlenen Einnahmezeitpunkt in Bezug auf eine Mahlzeit angibt. Beispielsweise können vor einer Mahlzeit einzunehmende Präparate länglich, während der Mahlzeit einzunehmende kreisförmig und nach der Mahlzeit einzunehmende Medikamente dreieckig geformt sein. Wenn der Anwendungszeitpunkt bezüglich einer Mahlzeit egal ist, kann beispielsweise eine Kugelform vorgesehen sein.The object is achieved by a packaged product combination according to claim 1 comprising a plurality of different drugs or the like., Wherein the form and / or color of the medication itself indicates an application information to the drug, namely a recommended intake time in relation to a meal. For example, preparations to be taken before a meal may be oblong, triangular shaped, taken during the meal and taken post-meal be. If the application time with respect to a meal does not matter, for example, a spherical shape may be provided.

Alternativ läßt sich der Einnahmezeitpunkt bezüglich einer Mahlzeit auch durch eine Farbe codieren, z.B. gelb vor der Mahlzeit, grün währenddessen, blau danach und rot, wenn der Einnahmezeitpunkt egal ist. Für sehbehinderte Patienten ist die Formcodierung naturgemäß jedoch besser geeignet.Alternatively, the time of ingestion with respect to a meal can also be coded by a color, e.g. yellow before the meal, green in the meantime, blue after and red if the time of taking it does not matter. Naturally, shape-coding is more suitable for visually impaired patients.

Die Blisterpackung ist mit mehreren, durch eine Folie jeweils verschlossenen Aufnahmefächern zur Aufnahme einer Anzahl der Medikamente versehen, welche Aufnahmefächer jeweils einer bestimmten Anwendungszeit (morgens, mittags, abends und ggf. nachts) innerhalb des festgelegten Anwendungszeitraums zugeordnet sind. Die Aufnahmefächer der Blisterpackung sind dabei in Matrixform mit einer Anzahl von Zeilen für Anwendungstage und Spalten für Anwendungszeiten während des Tages (morgens, mittags, abends und ggf. nachts) angeordnet sein. Die Blisterpackung kann vorzugsweise als Wochenblister für den Bedarf einer Woche ausgebildet sein.The blister pack is provided with a plurality of storage compartments, each closed by a film, for receiving a number of medicaments, which storage compartments are each assigned to a specific application time (morning, noon, evening and possibly night) within the specified period of application. The receiving compartments of the blister pack are arranged in a matrix form with a number of lines for application days and columns for application times during the day (morning, noon, evening and optionally at night). The blister pack may preferably be designed as a weekly blister for the needs of a week.

Die Blisterpackung kann Perforationsabschnitte aufweisen, die das Abtrennen einzelner (Tages-)Zeilen der matrixförmigen Blisterpackung erlaubt.The blister pack can have perforation sections which allow the separation of individual (daily) lines of the matrix-shaped blister pack.

Insbesondere kann die Produktzusammenstellung als personalisierte Produktzusammenstellung umfassend eine individuell festgelegte Medikamentenzusammenstellung für eine bestimmte Person für einen festgelegten Zeitraum ausgebildet sein.In particular, the product compilation can be designed as a personalized product compilation comprising an individually defined drug compilation for a specific person for a defined period of time.

Bei den Produkten kann es sich um Medikamente, Vitaminpräparate, Nahrungsergänzungsmittel etc. handeln.The products may be medications, vitamin supplements, dietary supplements, etc.

Die Erfindung schlägt außerdem ein Verfahren zur Konfektionierung und Verpackung einer Produktzusammenstellung bestehend aus mehreren unterschiedlichen Medikamenten oder dgl. gemäß Anspruch 7 vor.The invention also proposes a method for packaging and packaging a product combination comprising a plurality of different medicaments or the like according to claim 7.

Kurze Beschreibung der ZeichnungenBrief description of the drawings

Die Erfindung wird im folgenden anhand von Ausführungsbeispielen unter Bezugnahme auf die Zeichnungen im Detail beschrieben.

Figur 1
zeigt eine schematische Perspektivansicht eines Wochenblisters gemäß einem Ausführungsbeispiel der Erfindung.
Figur 2
zeigt eine Querschnittsansicht des Wochenblisters aus Figur 1.
Figur 3
zeigt beispielhaft in Seiten- bzw. Perspektivansicht und in Aufsicht verschiedene mögliche Medikamentenformen.
The invention will be described below in detail with reference to embodiments with reference to the drawings.
FIG. 1
shows a schematic perspective view of a weekly blister according to an embodiment of the invention.
FIG. 2
shows a cross-sectional view of the weekly blister FIG. 1 ,
FIG. 3
shows exemplary in side or perspective view and in supervision various possible forms of medication.

Detaillierte Beschreibung der ErfindungDetailed description of the invention

Figur 1 zeigt ein Ausführungsbeispiel einer erfindungsgemäßen personalisierten Blisterpackung 20. Diese ist als sogenannter Wochenblister ausgebildet zur Versorgung einer Person bzw. eines Patienten mit Medikamenten und ähnlichen Produkten wie etwa Vitaminpräparaten, Nahrungsergänzungsmitteln etc. für den Zeitraum von einer Woche. Selbstverständlich ist die Erfindung nicht auf einen bestimmten Zeitraum beschränkt. Für jeden Tag der Woche ist bei der insgesamt matrixförmigen Blisterpackung 20 eine durch eine Perforation 24 abtrennbare Zeile von in dem gezeigten Beispiel vier Aufnahmefächern 22 vorgesehen, die jeweils die anzuwendenden Produkte für "früh" ("morgens"), "mittags", "abends" oder "nachts" bzw. für "zum Frühstück", "zum Mittagessen", "zum Abendessen" und "vor dem Schlafengehen" enthalten. Je nach Anwendungsgebiet kann auch eine andere Zahl von Aufnahmefächern 22 vorgesehen sein. FIG. 1 shows an embodiment of a personalized blister pack according to the invention 20. This is designed as a so-called weekly blister for supplying a person or a patient with medicines and similar products such as vitamin supplements, dietary supplements, etc. for a period of one week. Of course, the invention is not limited to a specific period of time. For each day of the week is provided in the total matrix-shaped blister pack 20 a detachable by a perforation line of four in the example shown four storage compartments 22, each of the applied products for "early"("morning"),"noon","evening or "at night" or "for breakfast", "for lunch", "for dinner" and "before bedtime". Depending on the field of application, a different number of receiving compartments 22 may be provided.

Die - in dem in Figur 1 gezeigten Ausführungsbeispiel - insgesamt 28 Aufnahmefächer 22 sind aus einem vorzugsweise durchsichtigen thermoplastischen Material preiswert in Massenanfertigung durch Tiefziehen hergestellt und haben genügend Platz für jeweils eine Mehrzahl von Tabletten, Kapseln, Dragees etc. Alle Aufnahmefächer 22 können durch eine gemeinsame Folie 30, bspw. eine dünne Aluminiumfolie, verschlossen sein und mit Symbolen für die Einnahmezeit (morgens, mittags, abend, nachts) versehen sein. Weiterhin kann ein vorzugsweise klappbar an die Blisterpackung 20 angeformter Deckel (nicht dargestellt) zur Abdeckung der Folie 30 mit Beschriftungsflächen zum Aufdrucken von detaillierter Anwendungsinformation vorgesehen sein.The - in the in FIG. 1 shown embodiment - a total of 28 receiving compartments 22 are made of a preferably transparent thermoplastic material inexpensively mass-produced by deep drawing and have enough space for a plurality of tablets, capsules, dragees, etc. All receiving compartments 22 can by a common film 30, for example. A thin Aluminum foil, to be closed and provided with symbols for the intake time (morning, noon, evening, night). Furthermore, a preferably hinged to the blister pack 20 molded lid (not shown) may be provided to cover the film 30 with labeling surfaces for printing detailed application information.

Der Patient kann durch Aufreißen der dünnen Folie bequem die zur jeweiligen Tageszeit einzunehmenden Produkte entnehmen. Durch die Perforation 24 sowohl der die Aufnahmefächer 22 bildenden Kunststoffplatine als auch der Folie 30 können von der Blisterpackung 20 Tagesstreifen zur bequemen Mitnahme abgetrennt werden.By tearing the thin foil, the patient can comfortably remove the products to be taken at the time of day. Through the perforation 24 of both the receiving compartments 22 forming plastic board and the film 30 can be separated from the blister pack 20 day strips for convenient driving.

Figur 2 zeigt den in Figur 1 abgebildeten Wochenblister 20 in Querschnittsansicht. Die vier Aufnahmefächer 22 für morgens, mittags, abends und nachts sind gut zu erkennen; ebenso die darin befindlichen Produkte 10. Diese haben unterschiedliche Formen (länglich, kugel- oder zylinderförmig oder dreieckig), die jeweils eine Anwendungsbedingung, beispielsweise den Einnahmezeitpunkt in Bezug auf eine Mahlzeit abgeben. FIG. 2 shows the in FIG. 1 pictured weekly blister 20 in cross-sectional view. The four storage compartments 22 for morning, noon, evening and night are easy to recognize; as well as the products 10 therein. These have different shapes (oblong, spherical or cylindrical or triangular), each giving an application condition, for example, the time of ingestion with respect to a meal.

Figur 3 zeigt beispielhaft vier unterschiedliche Produktformen, in der oberen Zeile in Seiten- bzw. teilperspektivischer Ansicht, in der unteren Zeile in Aufsicht. Figur 3a zeigt ein kugelförmiges, Figur 3b ein kreis- bzw. zylinderförmiges, Figur 3c ein längliches (zigarrenförmiges) und Figur 3d ein dreieckiges Präparat. So kann etwa die Zylinderform einen Einnahmezeitpunkt vor der Mahlzeit, die längliche Form während der Mahlzeit und die dreieckige Form nach der Mahlzeit angeben. Wenn der Einnahmezeitpunkt bezüglich einer Mahlzeit egal ist, kann beispielsweise die Kugelform verwendet werden. So kann sich der Patient auf einfache Weise orientieren, welche Präparate er vor, während und nach dem Essen einnehmen soll. FIG. 3 shows by way of example four different product forms, in the upper row in side or partial perspective view, in the lower row in supervision. FIG. 3a shows a spherical, FIG. 3b a circular or cylindrical, Figure 3c an oblong (cigar-shaped) and 3d figure a triangular preparation. For example, the cylindrical shape may indicate a pre-meal intake, the oblong shape during the meal, and the triangular shape after the meal. If the intake time with respect to a meal does not matter, for example, the Be used spherical shape. This allows the patient to easily find out which preparations to take before, during and after meals.

Alternativ/zusätzlich kann auch eine Farbcodierung (nicht in den Figuren dargestellt) der Einnahmezeitpunkte vorgesehen sein, beispielsweise gelbe Tabletten vor der Mahlzeit, grüne währenddessen, blaue danach und rot, wenn der Einnahmezeitpunkt egal ist..Alternatively / additionally, a color coding (not shown in the figures) of the intake times may be provided, for example, yellow tablets before the meal, green during, blue after and red, if the time of administration is no matter.

Anstatt des Einnahmezeitpunktes in bezug auf eine Mahlzeit kann im Rahmen der Erfindung durch Form und/oder Farbe auch andere Produktinformation codiert sein. Beispielsweise kann der Einnahmezeitpunkt in bezug auf eine Mahlzeit durch die Form und eine andere präparatspezifische Information durch die Farbe angegeben werden.Instead of taking the meal in relation to a meal, other product information may also be coded by shape and / or color within the scope of the invention. For example, the time of administration with respect to one meal may be indicated by the form and another preparation-specific information by the color.

So unterstützen die erfindungsgemäße abgepackte Produktzusammenstellung und das erfindungsgemäße Verfahren eine bedarfsgerechte Medikation des Patienten, so dass dieser länger in der Lage ist, sich selbst zu versorgen und nicht auf stationäre Pflege angewiesen ist.Thus, the packaged product combination according to the invention and the method according to the invention support a need-based medication of the patient, so that he is able to care for himself longer and is not dependent on in-patient care.

Claims (11)

  1. Packaged product combination consisting of a blister pack (20) having a number of receiving compartments (22) which are sealed by a film (30) in each case, comprising a number of different medicaments (10) of different shape and/or colour, wherein the receiving compartments (22) of the blister pack (20) are arranged in the form of a matrix, with a number of lines for days of use and columns for times of use during the day, wherein the shape and/or colour of the medicaments (10) themselves indicate(s) a recommended ingestion time with reference to a meal, for the particular medicament (10).
  2. Packaged product combination according to claim 1, wherein the prescribed period is one week and the blister pack (20) is designed as a "week" blister pack for a week's requirements.
  3. Packaged product combination according to claim 1 or 2, having a cover, which is formed onto the blister pack (20), preferably in a foldable manner, for covering the film (30), and with lettering faces for printing on information regarding use.
  4. Packaged product combination according to one of claims 1 to 3, having sections (24) with perforations which allow the severing of individual lines of the matrix-shaped blister pack.
  5. Packaged product combination according to one of claims 1 to 4, which is designed as a personalised product combination for packaging an individually prescribed combination of medicaments for a specific person for a prescribed period.
  6. Packaged product combination according to one of claims 1 to 5, wherein said product combination comprises products such as medicaments, vitamin preparations, dietary supplements, etc.
  7. Method of making up and packaging a product combination consisting of a number of different medicaments of different shape and/or colour, wherein the medicaments (10) for a prescribed period of use are packaged in a number of receiving compartments (22) of a blister pack (20), which are sealed by a film (30) in each case, which receiving compartments (22) are each assigned to a specific time of use within the prescribed period, and wherein the shape and/or colour of the medicaments (10) themselves is/are so designed that it/they indicate(s) a recommended ingestion time with reference to a meal, for the particular medicament (10).
  8. Method according to claim 7, wherein the receiving compartments (22) of the blister pack (20) are arranged in the form of a matrix, with a number of lines for days of use and columns for times of use during the day, into which receiving compartments (22) the products are filled in a suitably organised manner.
  9. Method according to claim 8, wherein the prescribed period is one week.
  10. Method according to one of claims 7 to 9, wherein the product combination is an individually prescribed combination of medicaments for a specific person for a prescribed period.
  11. Method according to one of claims 7 to 10, wherein the product combination comprises products such as medicaments, vitamin preparations, dietary supplements, etc.
EP07101975A 2007-02-08 2007-02-08 Packaged product mix Not-in-force EP1955687B1 (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
PL07101975T PL1955687T3 (en) 2007-02-08 2007-02-08 Packaged product mix
DK07101975.6T DK1955687T3 (en) 2007-02-08 2007-02-08 Wrapped product assembly
AT07101975T ATE456356T1 (en) 2007-02-08 2007-02-08 PACKAGED PRODUCT COMPILATION
DE502007002736T DE502007002736D1 (en) 2007-02-08 2007-02-08 Packaged product compilation
EP07101975A EP1955687B1 (en) 2007-02-08 2007-02-08 Packaged product mix
ES07101975T ES2338474T3 (en) 2007-02-08 2007-02-08 ASSORTMENT OF PACKED PRODUCTS.
AU2008213050A AU2008213050A1 (en) 2007-02-08 2008-01-28 Packaged product combination
CA002677292A CA2677292A1 (en) 2007-02-08 2008-01-28 Packaged product combination
JP2009548650A JP2010517651A (en) 2007-02-08 2008-01-28 Packaged product combinations
US12/524,627 US20100108559A1 (en) 2007-02-08 2008-01-28 Packaged product combination
PCT/EP2008/050953 WO2008095810A1 (en) 2007-02-08 2008-01-28 Packaged product combination

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP07101975A EP1955687B1 (en) 2007-02-08 2007-02-08 Packaged product mix

Publications (2)

Publication Number Publication Date
EP1955687A1 EP1955687A1 (en) 2008-08-13
EP1955687B1 true EP1955687B1 (en) 2010-01-27

Family

ID=38179466

Family Applications (1)

Application Number Title Priority Date Filing Date
EP07101975A Not-in-force EP1955687B1 (en) 2007-02-08 2007-02-08 Packaged product mix

Country Status (11)

Country Link
US (1) US20100108559A1 (en)
EP (1) EP1955687B1 (en)
JP (1) JP2010517651A (en)
AT (1) ATE456356T1 (en)
AU (1) AU2008213050A1 (en)
CA (1) CA2677292A1 (en)
DE (1) DE502007002736D1 (en)
DK (1) DK1955687T3 (en)
ES (1) ES2338474T3 (en)
PL (1) PL1955687T3 (en)
WO (1) WO2008095810A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2459089B (en) * 2008-04-07 2012-11-14 Protomed Ltd A packaging system
US20120145585A1 (en) 2010-12-08 2012-06-14 Id-Con, Llc Packaging systems and methods
EP2734171B1 (en) 2011-07-19 2016-09-07 Id-Con, LLC Packaging systems and methods
CA2887607C (en) * 2012-10-08 2017-10-17 The Procter And Gamble Company Child-resistant blister package
USD756804S1 (en) * 2014-10-21 2016-05-24 Bradley Gross Combined holiday box and tray
USD770303S1 (en) 2015-02-03 2016-11-01 Chiasma Inc. Overlay for medication card
US9642773B2 (en) * 2015-02-03 2017-05-09 Chiasma Inc. Overlay for medication card
JP6035469B1 (en) * 2016-04-01 2016-11-30 株式会社Ｗｉｎｄｙ Medicine calendar, medication monitoring system using medicine calendar, and medicine calendar individual manufacturing system
CN108298113A (en) * 2018-01-04 2018-07-20 深圳中科华驰科技有限公司 Semi-automatic medicine-packaging machine
JP6548844B1 (en) * 2019-01-08 2019-07-24 株式会社Ｗｉｎｄｙ Method for collecting each medicine container from a medicine calendar for a plurality of patients so as to cross a plurality of patients for a specific or each dosing day or dosing cycle, and a container separating and feeding device for the medicine calendar

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US611136A (en) * 1898-09-20 Package for medical preparations
US3125490A (en) * 1964-03-17 Tablet with contrasting indicia and method
US4039080A (en) * 1976-03-23 1977-08-02 Joseph Anthony Cappuccilli Dosage indicating pill tray
US4148273A (en) * 1976-09-07 1979-04-10 Hollingsworth Delbert L Medicine management device
DE2834226A1 (en) * 1978-08-04 1980-02-28 Merck Patent Gmbh Multilayer tabletting system for pharmaceutical prods. - with separate filler spaces and split bottom plunger
IL58649A (en) * 1978-11-10 1982-04-30 Beecham Group Ltd Pharmaceutical dispensing container
US4473156A (en) * 1982-11-05 1984-09-25 St. Paul-Ramsey Hospital Medical Method and apparatus for accurately selecting storing and dispensing pills
GB8518828D0 (en) * 1985-07-25 1985-08-29 American Home Prod Tablet package
SE515129C2 (en) * 1996-07-01 2001-06-11 Astrazeneca Ab Blister pack, apparatus and method for manufacturing a blister pack and use of a blister pack
US5788974A (en) * 1996-09-11 1998-08-04 D'amico; Steven A. Helicobacter pylori treatment compliance pack
US6041932A (en) * 1999-02-10 2000-03-28 Holmberg; Doublas A. Vitamin organizing, storing and dispensing system
US6375956B1 (en) * 1999-07-22 2002-04-23 Drugtech Corporation Strip pack
JP3438039B2 (en) * 2001-01-15 2003-08-18 勝夫 磯 Holders for drugs or health supplements
US6681935B1 (en) * 2002-04-02 2004-01-27 Graham L. Lewis Method of providing a therapeutic regimen and prefabricated container therefor
DE102004034024A1 (en) * 2004-04-26 2006-02-09 Klingel, Hans, Dr.-Ing. h.c. Packaging unit for patient requiring weekly medication e.g. capsule, has lid folded from position covering blank to position releasing opening side of blank, where unit has configuration of printable fields for patient and medications data

Also Published As

Publication number Publication date
PL1955687T3 (en) 2010-07-30
JP2010517651A (en) 2010-05-27
DE502007002736D1 (en) 2010-03-18
AU2008213050A1 (en) 2008-08-14
EP1955687A1 (en) 2008-08-13
CA2677292A1 (en) 2008-08-14
WO2008095810A1 (en) 2008-08-14
US20100108559A1 (en) 2010-05-06
ATE456356T1 (en) 2010-02-15
DK1955687T3 (en) 2010-05-25
ES2338474T3 (en) 2010-05-07

Similar Documents

Publication Publication Date Title
EP1955687B1 (en) Packaged product mix
DE10030318C1 (en) Pharmaceutical packaging for eradication therapy
DE60310144T2 (en) SUPPLY VESSEL
CH641668A5 (en) BLISTER PACK.
DE69221091T2 (en) Dispenser for single-portion dispensing of pharmaceuticals
EP0718208B1 (en) Blister package
EP3341303B1 (en) Blister pack
DE69506267T2 (en) BLISTER PACK WITH DRYING AGENT
EP1872765A1 (en) Personalized blister pack and method for automated packaging of an individually determined composition
DE202005020811U1 (en) Packaging unit for patient requiring weekly medication e.g. capsule, has lid folded from position covering blank to position releasing opening side of blank, where unit has configuration of printable fields for patient and medications data
CA2128692A1 (en) System and apparatus for accurate drug inventory control
DE20314741U1 (en) Blister pack, for medications, has a printed backing where the blisters are divided into groups of seven with the days of the week printed, as a dosage calendar
DE602004008704T2 (en) Blister pack for the visually impaired
EP1572546B1 (en) Method for covering a transparent container used in clinical trials, and device therefor
DE69122760T2 (en) TABLET PACK
DE2018754C3 (en) Pack for dosage units, in particular tablets, capsules and the like
WO2011029421A1 (en) Security label for securing medications retained in an individual packaging
DE102017215917A1 (en) Individual blister packaging, packaging machine and method of making an individual blister package
DE29719070U1 (en) Blister for combination therapy
DE20319905U1 (en) Dosing packaging for medicines comprises a carrier card, a film containing moulded depressions, and a sealing covering film
DE60313676T2 (en) dispensing container
DE3924016A1 (en) Pill distributor tube - with indicator for work day or for number of pills left
DE29913195U1 (en) Combination pack for medication
DE1969225U (en) DOSAGE PACK FOR PHARMACEUTICAL PREPARATIONS.
DE202006021043U1 (en) Drug supply system

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20080124

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA HR MK RS

AKX Designation fees paid

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

Free format text: NOT ENGLISH

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: NV

Representative=s name: RENTSCH & PARTNER

REF Corresponds to:

Ref document number: 502007002736

Country of ref document: DE

Date of ref document: 20100318

Kind code of ref document: P

REG Reference to a national code

Ref country code: SE

Ref legal event code: TRGR

REG Reference to a national code

Ref country code: NL

Ref legal event code: T3

REG Reference to a national code

Ref country code: ES

Ref legal event code: FG2A

Ref document number: 2338474

Country of ref document: ES

Kind code of ref document: T3

REG Reference to a national code

Ref country code: DK

Ref legal event code: T3

LTIE Lt: invalidation of european patent or patent extension

Effective date: 20100127

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20100127

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20100527

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20100527

REG Reference to a national code

Ref country code: PL

Ref legal event code: T3

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20100127

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20100127

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20100127

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20100301

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20100127

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20100428

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20100127

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20100127

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20100127

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20100427

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed

Effective date: 20101028

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: PL

Payment date: 20101117

Year of fee payment: 5

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: TR

Payment date: 20110127

Year of fee payment: 5

Ref country code: CH

Payment date: 20110222

Year of fee payment: 5

Ref country code: CZ

Payment date: 20110203

Year of fee payment: 5

PGRI Patent reinstated in contracting state [announced from national office to epo]

Ref country code: IT

Effective date: 20110501

REG Reference to a national code

Ref country code: CH

Ref legal event code: PFA

Owner name: KOHL, EDWIN

Free format text: KOHL, EDWIN#IM HOLZHAU 8#66663 MERZIG (DE) -TRANSFER TO- KOHL, EDWIN#IM HOLZHAU 8#66663 MERZIG (DE)

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: HU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20100728

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20100208

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20120229

Ref country code: CZ

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20120208

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20120229

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: TR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20120208

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PL

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20120208

REG Reference to a national code

Ref country code: PL

Ref legal event code: LAPE

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: NL

Payment date: 20150223

Year of fee payment: 9

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DK

Payment date: 20150223

Year of fee payment: 9

Ref country code: IE

Payment date: 20150217

Year of fee payment: 9

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: SE

Payment date: 20150223

Year of fee payment: 9

Ref country code: AT

Payment date: 20150218

Year of fee payment: 9

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: BE

Payment date: 20150216

Year of fee payment: 9

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 10

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20160229

REG Reference to a national code

Ref country code: DK

Ref legal event code: EBP

Effective date: 20160229

REG Reference to a national code

Ref country code: SE

Ref legal event code: EUG

REG Reference to a national code

Ref country code: AT

Ref legal event code: MM01

Ref document number: 456356

Country of ref document: AT

Kind code of ref document: T

Effective date: 20160208

REG Reference to a national code

Ref country code: NL

Ref legal event code: MM

Effective date: 20160301

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20160208

Ref country code: SE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20160209

REG Reference to a national code

Ref country code: IE

Ref legal event code: MM4A

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20160301

Ref country code: DK

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20160229

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20160208

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 11

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20170220

Year of fee payment: 11

Ref country code: DE

Payment date: 20170228

Year of fee payment: 11

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20170221

Year of fee payment: 11

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: IT

Payment date: 20170217

Year of fee payment: 11

Ref country code: ES

Payment date: 20170220

Year of fee payment: 11

REG Reference to a national code

Ref country code: DE

Ref legal event code: R119

Ref document number: 502007002736

Country of ref document: DE

GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 20180208

REG Reference to a national code

Ref country code: FR

Ref legal event code: ST

Effective date: 20181031

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20180901

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20180208

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20180208

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20180228

REG Reference to a national code

Ref country code: ES

Ref legal event code: FD2A

Effective date: 20190801

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: ES

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20180209